
### [NCIT:C26768](http://purl.obolibrary.org/obo/NCIT_C26768)
**Label:** Eyelid Disorder

**Subclasses:** [NCIT:C4355](http://purl.obolibrary.org/obo/NCIT_C4355) (Eyelid Squamous Cell Papilloma), [NCIT:C6786](http://purl.obolibrary.org/obo/NCIT_C6786) (Malignant Eyelid Neoplasm), [NCIT:C134831](http://purl.obolibrary.org/obo/NCIT_C134831) (Eyelid Sebaceous Gland Carcinoma), [NCIT:C4357](http://purl.obolibrary.org/obo/NCIT_C4357) (Eyelid Capillary Hemangioma), [NCIT:C4358](http://purl.obolibrary.org/obo/NCIT_C4358) (Eyelid Melanoma), [NCIT:C6078](http://purl.obolibrary.org/obo/NCIT_C6078) (Eyelid Carcinoma), [NCIT:C26768](http://purl.obolibrary.org/obo/NCIT_C26768) (Eyelid Disorder), [NCIT:C3880](http://purl.obolibrary.org/obo/NCIT_C3880) (Eyelid Nevus), [NCIT:C4354](http://purl.obolibrary.org/obo/NCIT_C4354) (Benign Eyelid Neoplasm), [NCIT:C4061](http://purl.obolibrary.org/obo/NCIT_C4061) (Eyelid Papilloma), [NCIT:C3031](http://purl.obolibrary.org/obo/NCIT_C3031) (Eyelid Neoplasm), [NCIT:C88133](http://purl.obolibrary.org/obo/NCIT_C88133) (Stage IV Eyelid Carcinoma), [NCIT:C88127](http://purl.obolibrary.org/obo/NCIT_C88127) (Stage II Eyelid Carcinoma), [NCIT:C88120](http://purl.obolibrary.org/obo/NCIT_C88120) (Stage 0 Eyelid Carcinoma), 

**Class expressions from DL-Learner:**

- [NCIT:C26768](http://purl.obolibrary.org/obo/NCIT_C26768) (Eyelid Disorder) 96.67%
- [NCIT:C3031](http://purl.obolibrary.org/obo/NCIT_C3031) (Eyelid Neoplasm) 93.33%
- [NCIT:C6786](http://purl.obolibrary.org/obo/NCIT_C6786) (Malignant Eyelid Neoplasm) 73.33%
- [NCIT:C6078](http://purl.obolibrary.org/obo/NCIT_C6078) (Eyelid Carcinoma) 66.67%
- [NCIT:C6079](http://purl.obolibrary.org/obo/NCIT_C6079) (Eye Carcinoma) and [NCIT:C6786](http://purl.obolibrary.org/obo/NCIT_C6786) (Malignant Eyelid Neoplasm) 66.67%
- [NCIT:C3031](http://purl.obolibrary.org/obo/NCIT_C3031) (Eyelid Neoplasm) and [NCIT:C6079](http://purl.obolibrary.org/obo/NCIT_C6079) (Eye Carcinoma) 66.67%
- [NCIT:C26768](http://purl.obolibrary.org/obo/NCIT_C26768) (Eyelid Disorder) and [NCIT:C6079](http://purl.obolibrary.org/obo/NCIT_C6079) (Eye Carcinoma) 66.67%
- [NCIT:C26767](http://purl.obolibrary.org/obo/NCIT_C26767) (Eye Disorder) 65.10%
- [NCIT:C4354](http://purl.obolibrary.org/obo/NCIT_C4354) (Benign Eyelid Neoplasm) 63.33%
- [NCIT:C3030](http://purl.obolibrary.org/obo/NCIT_C3030) (Eye Neoplasm) 61.73%
- Thing 51.69%
- [NCIT:C27551](http://purl.obolibrary.org/obo/NCIT_C27551) (Disorder by Site) 49.04%
- [NCIT:C2991](http://purl.obolibrary.org/obo/NCIT_C2991) (Disease or Disorder) 48.96%
- [NCIT:C7057](http://purl.obolibrary.org/obo/NCIT_C7057) (Disease, Disorder or Finding) 48.96%
- [NCIT:C3262](http://purl.obolibrary.org/obo/NCIT_C3262) (Neoplasm) 45.61%


